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One in six people is likely to have a stroke in their lifetime, and 
the condition remains a leading cause of death and adult disability 
worldwide. For years, stroke patients were treated with ‘benign 
neglect’ based on the premise that the stroke victim’s fate was 
sealed soon after onset and nothing much could be done apart 
from calling in the rehabilitation team a few days later if the patient 
survived. However, there have been four major quantum leaps in the 
management of acute stroke over the past decade or two that have 
resulted in improved outcomes.
The stroke unit model of care, embracing the concept of a 
multidisciplinary team working synchronously using standard 
operating procedures and pathways to maintain homeostasis, initiate 
appropriate early rehabilitation and prevent complications, has been 
shown in numerous studies worldwide to be effective in improving 
outcome by reducing both mortality and morbidity. This model of 
care was shown to be effective in substantially reducing mortality 
in a small under-resourced community hospital in Western Cape 
Province, South Africa (SA).[1]
Reperfusion therapy in the form of intravenous thrombolysis with 
tissue plasminogen activator (tPA) was the next major leap in the 
management of acute ischaemic stroke. Despite occasional sporadic 
dissenting voices concerned with the very real risks of this treatment 
modality, intravenous thrombolysis has been recommended as an 
option for suitable patients by the World Stroke Organization, the 
European Stroke Organisation and most individual country stroke 
societies including the South African Stroke Society.[2] Although 
intravenous thrombolysis may be associated with bleeding and 
worsening of the stroke, and even death in a small percentage of 
patients, the net benefit exceeds the risk in carefully selected patients, 
resulting in an increased number of patients whose stroke symptoms 
are reversed or lessened by the treatment. The indications for, 
contraindications to and potential benefit and harm of intravenous 
thrombolysis have been well elucidated in the various guidelines 
including the most recent American Heart Association/American 
Stroke Association guideline published in 2018.[3] However, the 
narrow therapeutic window from symptom onset to treatment with 
a thrombolytic agent is one of the major limitations hindering its 
widespread use in clinical practice.
The next leap forward was the advent of intra-arterial mechanical 
thrombectomy (MTB) for acute ischaemic stroke within 6 hours 
of symptom onset, shown in studies to result in the most striking 
and dramatic improvements in outcomes in selected patients with 
proximal cerebral artery occlusions.[4-8] However, the procedure 
requires highly skilled trained interventionalists working in high-
volume centres to achieve good results with low complication rates 
(not insignificant even in good hands). Patient selection, operator 
skill and timing of MTB are all key determinants of outcome. At 
present in SA this procedure is limited to one or two centres in the 
large metropoles.
More recently, an exciting leap at the frontier of stroke management 
has been the development of advanced radiological software for use 
on computed tomography (CT) or magnetic resonance imaging 
providing automated perfusion studies (e.g. RAPID, a validated 
software that has been used in clinical trials). When executed 
consistently and interpreted correctly, such automated CT perfusion 
studies can identify appropriate candidates for thrombectomy. Such 
software is becoming an important decision-making tool, because 
it can rapidly identify those patients who have salvageable brain 
tissue and can benefit from thrombectomy.[9,10] Individuals can be 
differentiated into those with or without salvageable brain tissue, or 
for whom the benefits of thrombectomy outweigh the risks. Recent 
trials have extended the treatment window substantially by showing 
long-lasting benefit of thrombectomy in a subset of ischaemic stroke 
patients who present within 24 hours of symptom onset.[11,12] Given 
the inherent risk of both reperfusion modalities, compliance with 
recommended guidelines has become all the more important in order 
to maximise the potential benefit and reduce the associated risks of 
this treatment.
The pervading medical litigious environment in SA has led to an 
increasing number of malpractice lawsuits, including those in which 
hospitals and doctors are being sued for not acting with urgency 
and offering the option of reperfusion therapy to patients who 
arrive in the EU within the required time window for reperfusion. 
Stroke treatment is very much in the cross hairs of malpractice 
lawyers, and failure to act in accordance with our own guideline, 
and every other published guideline, including failure to discuss 
the option of reperfusion in suitably selected patients, is now being 
used as the basis for the lawsuits. This situation makes the study by 
Mandizvidza et al.[13] published in this issue of SAMJ all the more 
relevant, as it is going to be increasingly difficult to defend future 
claims, particularly as large public hospitals such as Groote Schuur, 
Tygerberg, Livingstone and Johannesburg General have been able to 
administer such treatment to suitable patients with acute ischaemic 
stroke for some time now.
Fortunately in the past 2 years there has been enormous progress, 
largely as a result of the Angels Initiative (an industry-sponsored 
initiative that has been endorsed by the World Stroke Organization, 
the European Stroke Organisation and the South African Stroke 
Society) that has been responsible for on-site training in both public 
and private hospitals in all aspects of stroke care (with protocols 
based on international guideline recommendations and vetted by 
local stroke experts). Training has included on-site simulation testing 
in order to streamline reperfusion treatment for suitable patients 
with acute ischaemic stroke and reduce ‘door-to-needle’ times. Sadly, 
many SA hospitals are not up to scratch with treating their stroke 
patients and are now increasingly likely to be vulnerable to litigation. 
Although the study by Mandizvidza et al.[13] was undertaken in a 
sample of hospitals in the Cape Metro Health District, it almost 
certainly reflects the status quo elsewhere in the country, where 
conditions are often much worse. In hospitals that do not have 
the resources necessary for reperfusion therapy, treating stroke 
patients urgently without delay to maintain homeostasis and prevent 
complications and initiate secondary prevention adopting the stroke 
unit model of care should by now be possible at all levels of care, 
regardless of whether or not the patient is a candidate for any type of 
reperfusion therapy.
Given the considerable stroke burden in SA, an evaluation of 
the barriers to acute stroke care in the public health care sector 
(also present in many private hospitals) is timely in response to the 
failure of many hospitals with the capacity to react appropriately 
in managing such patients. The SA stroke guideline,[2] published in 
SAMJ 10 years ago, was tailored to the limited resources available 
at the different levels of the public health care sector. Although the 
Angels Initiative has done much to address the gaps in stroke care in 
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many hospitals throughout the country, it remains crucial to identify 
and address the remaining shortfalls and barriers to efficient stroke 
care in our setting.
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